Literature DB >> 32600623

Cost-effectiveness analysis of a large jail-based methadone maintenance treatment continuation program in New Mexico.

Brady P Horn1, Xiaoxue Li2, Barbara McCrady3, Paul Guerin4, Michael T French5.   

Abstract

The U.S. has the second-highest incarceration rate in the world and spends more than $80 billion annually to house inmates. The clinical research literature suggests that methadone maintenance treatment (MMT) is an effective method to treat opioid use disorders (OUD) and that jails are a potentially valuable environment to implement MMT. Currently, jail-based MMT is rarely implemented in practice, due in part to resource limitations and other economic considerations. The primary goal of this study was to perform a cost-effectiveness analysis (CEA) of jail-based MMT using data from a unique MMT continuation program located in a large urban jail in New Mexico. Recidivism data were collected for a three-year period both before and after incarceration, and quasi-control groups were constructed from both substance-using and general populations within the jail. Base models show that inmates enrolled in jail-based MMT exhibited significantly fewer days of incarceration due to recidivism (29.33) than a group of inmates with OUDs who did not receive MMT. Economic estimates indicate that it cost significantly less ($23.49) to reduce an incarcerated day using jail-based MMT than incarceration per se ($116.49). To mitigate potential sample selection bias, we used both propensity-score-matching and difference-in-differences estimators, which provided comparable estimates when using the OUD non-MMT comparison group. Difference-in-differences models find that, on average, MMT reduced recidivism by 24.80 days and it cost $27.78 to reduce an incarcerated day using jail-based MMT. Assuming a willingness to pay threshold of the break-even cost of reducing one incarcerated day, we estimate a 93.3% probability that this MMT program is cost-effective. Results were not as strong or consistent when using other comparison groups (e.g., alcohol-detoxified and general-population inmates). Overall, results suggest that it costs substantially less to provide jail-based MMT than incarceration alone. Jail administrators and policymakers should consider incorporating MMT in other jail systems and settings.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cost-effectiveness analysis; Jail; Methadone maintenance; Opioid use disorder; Recidivism

Mesh:

Substances:

Year:  2020        PMID: 32600623      PMCID: PMC9345512          DOI: 10.1016/j.jsat.2020.108042

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  26 in total

Review 1.  A research agenda for economic evaluation of substance abuse services.

Authors:  Michael T French; Michael Drummond
Journal:  J Subst Abuse Treat       Date:  2005-09

2.  The economic costs of jail-based methadone maintenance treatment.

Authors:  Brady P Horn; Xiaoxue Li; Saleh Mamun; Barbara McCrady; Michael T French
Journal:  Am J Drug Alcohol Abuse       Date:  2018-07-19       Impact factor: 3.829

3.  Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.

Authors:  Josiah D Rich; Michelle McKenzie; Sarah Larney; John B Wong; Liem Tran; Jennifer Clarke; Amanda Noska; Manasa Reddy; Nickolas Zaller
Journal:  Lancet       Date:  2015-05-28       Impact factor: 79.321

4.  Community-Based Methadone Maintenance in a Large Detention Center is Associated with Decreases in Inmate Recidivism.

Authors:  Verner S Westerberg; Barbara S McCrady; Mandy Owens; Paul Guerin
Journal:  J Subst Abuse Treat       Date:  2016-07-18

5.  Treating drug abuse and addiction in the criminal justice system: improving public health and safety.

Authors:  Redonna K Chandler; Bennett W Fletcher; Nora D Volkow
Journal:  JAMA       Date:  2009-01-14       Impact factor: 56.272

6.  Interim methadone treatment: impact on arrests.

Authors:  Robert P Schwartz; Jerome H Jaffe; Kevin E O'Grady; Timothy W Kinlock; Michael S Gordon; Sharon M Kelly; Monique E Wilson; Ashraf Ahmed
Journal:  Drug Alcohol Depend       Date:  2009-05-14       Impact factor: 4.492

7.  Methadone and buprenorphine prescribing and referral practices in US prison systems: results from a nationwide survey.

Authors:  Amy Nunn; Nickolas Zaller; Samuel Dickman; Catherine Trimbur; Ank Nijhawan; Josiah D Rich
Journal:  Drug Alcohol Depend       Date:  2009-07-21       Impact factor: 4.492

8.  The cost of crime to society: new crime-specific estimates for policy and program evaluation.

Authors:  Kathryn E McCollister; Michael T French; Hai Fang
Journal:  Drug Alcohol Depend       Date:  2010-01-13       Impact factor: 4.492

9.  A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.

Authors:  Timothy W Kinlock; Michael S Gordon; Robert P Schwartz; Terrence T Fitzgerald; Kevin E O'Grady
Journal:  J Subst Abuse Treat       Date:  2009-03-31

10.  When does methadone treatment reduce arrest and severity of arrest charges? An analysis of arrest records.

Authors:  Robert P Schwartz; Sharon M Kelly; Shannon Gwinn Mitchell; Jan Gryczynski; Kevin E O'Grady; Jerome H Jaffe
Journal:  Drug Alcohol Depend       Date:  2017-09-14       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.